Deborah A. Eppstein
18Patents
15h-index
16Co-inventors
75Inventor score
Filing activity: Jul 8, 1982 → Nov 9, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4522811A | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides | Human Necessities | 1,511 | Expired |
| US4897355A | N[.omega.,(.omega.-1)-dialkyloxy]- and N-[.omega.,(.omega.-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor | Emerging Cross-Sectional Technologies | 670 | Expired |
| US5458140A | Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers | Human Necessities | 501 | Expired |
| US5445611A | Enhancement of transdermal delivery with ultrasound and chemical enhancers | Human Necessities | 468 | Expired |
| US4946787A | N-(.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor | Chemistry; Metallurgy | 274 | Expired |
| US4962091A | Controlled release of macromolecular polypeptides | Human Necessities | 245 | Expired |
| US5049386A | N-.omega.,(.omega.-1)-dialkyloxy)- and N-(.omega.,(.omega.-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor | Chemistry; Metallurgy | 203 | Expired |
| US5208036A | N-(.omega., (.omega.-1)-dialkyloxy)- and N-(.omega., (.omega.-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor | Emerging Cross-Sectional Technologies | 186 | Expired |
| US5545412A | N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor | Emerging Cross-Sectional Technologies | 108 | Expired |
| US4684625A | Method for enhancing the anti-infective activity of muramyldipeptide derivatives | Performing Operations; Transporting | 61 | Expired |
| US5550289A | N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor | Emerging Cross-Sectional Technologies | 37 | Expired |
| US5783179A | C-reactive protein fragment with immunomodulatory activity | Human Necessities | 31 | Expired |
| US4606917A | Synergistic antiviral composition | Emerging Cross-Sectional Technologies | 22 | Expired |
| US6387395B1 | N-[1, (1-1) -dialkyloxy] - and N- [1, (1-1) -dialkenyloxy]- alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor | Emerging Cross-Sectional Technologies | 21 | Expired |
| US5366737A | N-[.omega.,(.omega.-1)-dialkyloxy]- and N-[.omega.,(.omega.-1)-dialkenyloxy]-alk-1-yl-N,N,N,-tetrasubstituted ammonium lipids and uses therefor | Emerging Cross-Sectional Technologies | 20 | Expired |
| US5622712A | N-[.omega., (.omega.-1)-dialkyloxy]- and N-[.omega., (.omega.-1)-dialkenyloxy]-alk-1-yl-N, N, N-tetrasubstituted ammonium lipids and uses therefor | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4857316A | Synergistic antiviral composition | Human Necessities | 7 | Expired |
| US10351823B2 | Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.